CommercialPrior AuthMedium impact
08.02.16a, Talquetamab-tgvs (Talvey®)
Independence Blue Cross·Oncology, Hematology·Pharmacy
Effective date
May 4, 2026
We identified it
Jun 19, 2026
Summary
A new policy for Talquetamab-tgvs (Talvey®), an oncology medication, has been updated with changes to medical necessity criteria and medical coding requirements. This affects billing and coverage determination for this specialty pharmaceutical drug.
Action Required
Before May 4, 2026: Billing team must review updated medical necessity criteria for Talquetamab-tgvs (Talvey®) and update any prior authorization documentation requirements in billing system. Oncology providers should ensure documentation meets new medical necessity standards for this medication.